Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series

Published:2022-02 Issue:2 Volume:10 Page:e0641
ISSN:2639-8028
Container-title:Critical Care Explorations
language:en
Short-container-title:

Author:

Yonker Lael M.,Swank Zoe,Gilboa Tal,Senussi Yasmeen,Kenyon Victoria,Papadakis Lena,Boribong Brittany P.,Carroll Ryan W.,Walt David R.,Fasano Alessio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference14 articles.

1. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study.;Tartof;Lancet,2021

2. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.;Yonker;J Clin Invest,2021

3. Virologic features of severe acute respiratory syndrome coronavirus 2 infection in children.;Yonker;J Infect Dis,2021

4. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.;Fasano;Lancet,2000

5. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.;Porritt;J Clin Invest,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Intestinal Epithelial Permeability in Multisystem Inflammatory Syndrome in Children: A Case–Control Study;COVID;2024-08-24

2. Zonulin as Gatekeeper in Gut–Brain Axis: Dysregulation in Glioblastoma;Biomedicines;2024-07-24

3. Multisystem inflammatory syndrome in children (MIS-C) and long Covid;Global Pediatrics;2024-03

4. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC);Nature Immunology;2023-09-04

5. Current understanding of epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children;Medicine of Extreme Situations;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3